User profiles for Antonio Pagliuca

ANTONIO PAGLIUCA

Professor of Haematology
Verified email at kcl.ac.uk
Cited by 11824

[HTML][HTML] COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

…, M Hoenigl, N Klimko, P Koehler, A Pagliuca… - Journal of hematology & …, 2021 - Springer
Background Patients with hematological malignancies (HM) are at high risk of mortality from
SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse …

The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS

…, A Mijovic, S Devereux, A Pagliuca - Blood, The Journal …, 2000 - ashpublications.org
Bone marrow CD34 + cell apoptosis (annexin V), proliferation (Ki-67), and Bcl-2-related
protein expression was evaluated by flow cytometry in 102 patients with myelodysplastic …

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two …

…, S Arnould, C Konto, P Veys, W Qasim, A Pagliuca… - The Lancet, 2020 - thelancet.com
Background Genome-edited donor-derived allogeneic anti-CD19 chimeric antigen receptor
(CAR) T cells offer a novel form of CAR-T-cell product that is available for immediate clinical …

[HTML][HTML] Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European …

…, M NiChonghaile, S Okamoto, A Pagliuca… - Bone marrow …, 2016 - nature.com
Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a
potentially life threatening complication that can develop after hematopoietic cell …

BCSH/BSBMT guideline: diagnosis and management of veno‐occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation

…, J Karani, A Quaglia, A Pagliuca… - British journal of …, 2013 - Wiley Online Library
of Key Recommendations Diagnosis It is recommended that the diagnosis of veno‐occlusive
disease (sinusoidal obstruction syndrome) [VOD (SOS)] be based primarily on established …

[HTML][HTML] Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European …

…, B Gruhn, A Lankester, F Locatelli, A Pagliuca… - Bone marrow …, 2018 - nature.com
The advances in hematopoietic cell transplantation (HCT) over the last decade have led to
a transplant-related mortality below 15%. Hepatic sinusoidal obstruction syndrome/veno-…

Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd–Chiari syndrome

…, M Thanigaikumar, D Yallop, R Arya, A Pagliuca… - Gastroenterology, 2006 - Elsevier
Background & Aims: Budd–Chiari Syndrome (BCS) results from obstruction to hepatic
venous outflow, with myeloproliferative disorder (MPD) accounting for up to 40% of cases. A …

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation

DI Marks, A Pagliuca, CC Kibbler… - British journal of …, 2011 - Wiley Online Library
Antifungal prophylaxis for allogeneic haematopoietic stem‐cell transplant (alloHCT) recipients
should prevent invasive mould and yeast infections (IFIs) and be well tolerated. This …

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

…, M Bonanni, F Passamonti, A Pagliuca… - Blood, The Journal …, 2022 - ashpublications.org
Limited data are available on breakthrough COVID-19 in patients with hematologic
malignancy (HM) after anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

…, N Klimko, P Koehler, A Pagliuca… - Blood, The Journal …, 2022 - ashpublications.org
In a Plenary Paper, Mittelman and colleagues assess the relative clinical efficacy of mRNA
vaccination on COVID-19 disease incidence and outcomes in patients with hematologic …